Product Information
URSODIOL 300 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4160 per EA under NDC 70710148301. Its NADAC has been published 269 times since Jun 30, 2021.
FDA first approved this application on Oct 16, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710148301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
URSODIOLApproval Type
Generic (ANDA)
FDA Application
ANDA214295FDA Approved
10/16/2020
TE Code
AB
On Market Since
1/21/2021
Pharmacological Classes
Price Statistics
The NADAC for URSODIOL 300 MG CAPSULE has been published 269 times since Jun 30, 2021, and over the history we have for it it has declined 17.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4160 per EA |
|---|---|
| All-time high | $0.6902 (Dec 14, 2022) |
| All-time low | $0.3666 (Jul 17, 2024) |
| 52-week high | $0.4998 |
| 52-week low | $0.4160 |
| Median price | $0.4911 |
| Average price | $0.5151 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 269 |
| Tracking since | Jun 30, 2021 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of URSODIOL 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for URSODIOL 300 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4160 per EA (NDC 70710148301), effective Aug 19, 2026.
How has the price of URSODIOL 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for URSODIOL 300 MG CAPSULE has declined 17.3%. It has been tracked across 269 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for URSODIOL 300 MG CAPSULE?
Since Jun 30, 2021, the NADAC for URSODIOL 300 MG CAPSULE has ranged from a low of $0.3666 (Jul 17, 2024) to a high of $0.6902 (Dec 14, 2022), with a median of $0.4911 per EA.
Are there cheaper alternatives to URSODIOL 300 MG CAPSULE?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as URSODIOL 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures URSODIOL 300 MG CAPSULE?
URSODIOL 300 MG CAPSULE (NDC 70710148301) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.